FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter maintenance therapy may be just as effective for ovarian cancer
Disease control Recruiting nowThis study tests whether taking the drug olaparib for one year works as well as taking it for two years to keep ovarian cancer from coming back. Participants have a specific genetic type of advanced ovarian cancer (BRCA mutation or HRD positive) and have already responded to init…
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 02:21 UTC
-
Promising combo therapy targets fluid buildup in recurrent ovarian cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and/or a targeted therapy (bevacizumab) can better control fluid buildup and tumor growth in people whose ovarian, fallopian tube, or peritoneal cancer has returned. About 60 ad…
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer?
Disease control Recruiting nowThis study tests the safety of giving heated chemotherapy directly into the abdomen during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 people will receive either the heated treatment after surgery or standard chemotherapy before surgery. The goal …
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: FALLOPIAN TUBE ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC